Jun 27 |
Vaxart Inc: Asymmetric Risk-Reward Opportunity Following BARDA Funding
|
Jun 22 |
While institutions invested in Vaxart, Inc. (NASDAQ:VXRT) benefited from last week's 23% gain, retail investors stood to gain the most
|
Jun 21 |
$1M Bet On This Penny Stock? Check Out These 4 Stocks Under $2 Insiders Are Aggressively Buying
|
Jun 18 |
Vaxart anticipates funds to extend its cash runway into 2026
|
Jun 17 |
Vaxart Provides Business Update
|
Jun 14 |
Biggest stock movers today: ADBE, MSM, RH, and more
|
Jun 14 |
Vaxart Bags $453M Worth BARDA-Funded Project, Seeks To Raise $40M Via Equity Offering
|
Jun 14 |
Vaxart to raise $40M via stock offering
|
Jun 13 |
Vaxart Announces $40 Million Underwritten Offering of Common Stock
|
Jun 13 |
Vaxart soars after hours on $453M award to evaluate COVID-19 oral pill vaccine candidate
|